{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:41:01Z","timestamp":1774359661262,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jogc.2015.11.005","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T17:45:18Z","timestamp":1455039918000},"page":"80-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding"],"prefix":"10.1016","volume":"38","author":[{"given":"Kristina","family":"Arendas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Leyland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jogc.2015.11.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: Focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.jogc.2015.11.005_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jogc.2015.11.005_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/00002018-200225110-00002","article-title":"A\u00a0benefit-risk assessment of medical treatment for uterine leiomyomas","volume":"25","author":"De Leo","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jogc.2015.11.005_bib4","unstructured":"Health Canada. Summary basis of decision (SBD): Fibristal; 2013. Available at http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/sbd-smd\/drug-med\/sbd_smd_2013_fibristal_156861-eng.php. Updated 2013. Last accessed on April 6,\u00a02015."},{"issue":"2","key":"10.1016\/j.jogc.2015.11.005_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejogrb.2011.04.025","article-title":"Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: Consensus from an international expert panel","volume":"158","author":"James","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.jogc.2015.11.005_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1701-2163(15)30939-7","article-title":"Clinical Practice \u2013 Gynaecology Committee. Abnormal uterine bleeding in pre-menopausal women","volume":"35","author":"Singh","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"2","key":"10.1016\/j.jogc.2015.11.005_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2012.02.021","article-title":"The imminent dawn of SPRMs in obstetrics and gynecology","volume":"358","author":"Chabbert-Buffet","year":"2012","journal-title":"Molecular & Cellular Endocrinology"},{"issue":"5","key":"10.1016\/j.jogc.2015.11.005_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jogc.2015.11.005_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/17460441.2011.602670","article-title":"Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas","volume":"6","author":"Maruo","year":"2011","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"10.1016\/j.jogc.2015.11.005_bib10","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2008-0731","article-title":"Persistence of an intact endometrial matrix and vessels structure in women exposed to VA-2914, a selective progesterone receptor modulator","volume":"93","author":"Ravet","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jogc.2015.11.005_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/01.AOG.0000238343.62063.22","article-title":"Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: A randomized controlled trial","volume":"108","author":"Munro","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogc.2015.11.005_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00404-013-2797-9","article-title":"Oral contraceptive use and uterine leiomyoma risk: A meta-analysis based on cohort and case-control studies","volume":"288","author":"Qin","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.jogc.2015.11.005_bib13","first-page":"253","article-title":"Low-dose combination oral contraceptives use in women with uterine leiomyomas","volume":"54","author":"Orsini","year":"2002","journal-title":"Minerva Ginecol"},{"issue":"3","key":"10.1016\/j.jogc.2015.11.005_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(98)00208-8","article-title":"A\u00a0prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata","volume":"70","author":"Marshall","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2015.11.005_bib15","first-page":"219","article-title":"Society of Obstetricians and Gynaecologists of Canada Contraception Guidelines Committee. Canadian contraception consensus. SOGC clinical practice guidelines, No. 143 (Part 2 of 3), March 2004","volume":"26","author":"Black","year":"2004","journal-title":"J\u00a0Obstet Gynaecol Can"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216315000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216315000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:28:09Z","timestamp":1761665289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216315000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1701216315000195"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2015.11.005","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2015.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}